Teva Introduces First Eliquis Rival In UK
Capitalizes On Recent Success In Litigation Over Apixaban With Originator BMS
Teva has capitalized on a recent legal victory in the UK by claiming the first launch of a generic apixaban rival to BMS’ Eliquis.